broprodifacoum;3-[3-(4'-bromo[1,1'-biphenyl]-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxy-2H-1-benzopyran-2-one

3-[3-(4'-bromobiphenyl-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxycoumarin

C₃₀H₂₃BrO₄

Formar Yellowish polvo.

Punto de fusion 200-210℃.

Densidad 1.5164.

Solubilidad en water 19 mg/l (20℃). en dimethylFormaramide 730, ethyl acetate 25, ethanol 8.2 (all en g/l, 20℃). Soluble en acetone; slightly soluble en chloroFormar; practically ensoluble en diethyl ether and hexane.

Agudo agudo oral LD50 para rats 1.125, mice 1.75, rabbits 1.00, dogs >10.0, cats >25.0 mg/kg.

Piel y ojos agudos percutaneous LD50 para rabbits 1.71 mg/kg.

Inhalación LC50 para hombre y mujerrats 0.43 mg/l.

Control of rats and mice (including those resistant to warfarin) in areas containing stored products, household use, industrial buildings, and other situations.

Descripción: White or off-white powder,libre de materia extraña visible;

Contenido de ingrediente activo(w/w): ≥98%;

Agua (w/w): ≤0.5%; Pérdida por secado(w/w): ≤1.0%;

pH Value: 5.0~9.0;

Bromadiolone A and B scale α(A/B): ≤0.3